Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03985280Phase 4Unknown
Phase 4, randomised, open-label trial in chronic hip pain and hip osteoarthritis (2 arms). Primary endpoints: Percentage of subjects with Visual Analog Scale reduction greater than 50% at 3 months and Persistence of clinical effect (VAS reduction > 50%) at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03985280.